Recombinant DNA Training for Research Group Members How to Use this Training Template Principal Investigators (PIs) whose research involves recombinant.

Slides:



Advertisements
Similar presentations
THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
Advertisements

Biological Laboratory Safety. REHS Rutgers Environmental Health and Safety REHS supports Rutgers University by providing comprehensive and professional.
BSL-2 Laboratory BIOHAZARD All Personal Protective Equipment shall be removed prior to leaving this work area. Eating, drinking, smoking applying cosmetics.
Module 6: Safety At the HIV Rapid Testing Site. Lab workersHealth workersCounselors 2 The Lab Quality System Process Control Quality Control & Specimen.
RYERSON UNIVERSITY 1 3. SETTING UP A LAB. RYERSON UNIVERSITY 2 Biological Safety Training – Certificate Holder and User Training 3. SETTING UP A LAB Topics.
Emergency Response to Biological Incidents Response to Biological Spills in the Laboratory (Intentional or Accidental)
Bloodborne Pathogens Control Plan Procedure Overview.
BIOLOGICAL HAZARDS RISK ASSESSMENT
Prepared by; Miss Syazwani Mahmad Puzi School of Bioprocess Engineering UniMAP.
UC Davis Safety Services Monthly Safety Spotlight April 2010: Chemical and Laboratory Safety Safety Discussion Topics Critical Questions to Ask Laboratory.
Risk Assessment in Animal Biosafety ► Risk Assessment Factors  Pathogen/agent  Animal Model (species)  Procedures ► Proposed manipulations ► Assigned.
Outline Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview.
UAF CHEMICAL HYGIENE PLAN (CHP) OVERVIEW University of Alaska Fairbanks Environmental, Health, Safety, and Risk Management May 2013.
Chapter 11 Safety and Health Elsevier items and derived items © 2009, 2005 by Saunders, an imprint of Elsevier Inc.
An Introduction to Biological Safety Dr. A. Mantalaris Biological Safety Officer (ACE 515, Tel: x45601)
17/05/20151 Chemical and Biological Hazards Department of Cell Physiology And Pharmacology Tim Walton Departmental Safety Officer.
 MIOSHA Standard for Hazardous Work in Laboratories  Methods and Observations Used to Detect the Presence or Release of a Hazardous Chemical  Permissible.
LAB SAFETY FOR CUSTODIANS. Lab Waste  Biological Waste  Chemical Waste  Regulated Medical Waste  Non- Regulated Medical Waste  Radioactive Waste.
Biosafety Program Development Presented by: Lisa Wisser, CIH AIHCE - June 6, 2001.
Safe Handling of Infectious Waste Procedure Overview.
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
East Carolina UniversityOffice of Prospective Health/Biological Safety Biological Safety Training.
Coming Soon... Mandatory Biosafety Training David W. Emery, Ph.D. Research Associate Professor of Medicine & Chair, Institutional Biosafety Committee On.
Institutional Biosafety Committee and Biological Use Authorization.
Environmental Health and Safety Radiation Control and Radiological Services.
Standard Microbiological Practices UT Biosafety Office
Research and Biological Safety Office Environmental Health and Safety
Safety Review and Approval Process for Research Proposals Robert Emery, DrPH, CHP, CIH, CBSP, CSP, CHMM, CPP, ARM Vice President for Safety, Health, Environment.
Foundation Training in Biological Safety. Module 4 Genetically modified organisms.
Laboratory Safety and Regulations
Student Safety Orientation. Origin of Safety Rules School Rules Classroom/Laboratory Rules Lab Safety Rule Agreement National Science Education Standards.
Bloodborne Pathogens Edgar Romo, REHS Environmental Health & Biosafety Specialist Janette De La Rosa Ducut, Ed.D. Training Manager.
NC A&T STATE UNIVERSITY
 Chemical Spill Procedures Environmental Health and Safety Office.
Introduction to the MUSC Institutional Biosafety Committee (IBC) Registration Process Daniel Eisenman, PhD MUSC Biosafety Officer
Research Protocol Registration at WUStL Institutional Biological and Chemical Safety Committee/ Environmental Health and Safety Joe Kanabrocki Biological.
7. EMERGENCY RESPONSE RYERSON UNIVERSITY.
Implementation of the NIH Guidelines Robert J. Hashimoto, CBSP University of Minnesota Minneapolis, Minnesota November 15, 2007.
INSTITUTIONAL REVIEW OF BIOSAFETY RESEARCH Review of Institutional Biosafety Committee Application Form Robert J. Hashimoto The University of Kentucky.
O FFICE OF S CIENCE & R ESEARCH OSR O FFICE OF S CIENCE & R ESEARCH OSR Welcome to Click Institutional Biosafety Committee (IBC) Learning Module.
Introduction to Biohazards: Risk Management
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Working with Biological Materials in the O’Connell Laboratory Grace O’Connell, PhD [Date Training Is Given]
Lab Specific Training June 14 th, Responsibilities completing all required safety training; reading the Lab Safety Plan and all lab standard operating.
SAFETY IN MEDICAL LAB.
Instructor:Mr. Wayne Wood McGill University Environmental Safety Office Chancellor Day Hall, room 615 Telephone:
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
Institutional Biosafety Committee Member Training October 2013.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Bloodborne Pathogens Bloodborne Pathogens Standard Unit 3.
Biological Agents, Biosafety cabinets and Beyond Biological Agents, Biosafety cabinets and Beyond Microbiology laboratory 2005.
Biological Waste from Laboratories
NC A&T STATE UNIVERSITY
Biosafety at Swinburne
Overview of the NIH Guidelines for Research Involving Recombinant DNA Molecules This is an edited combination of Haverford College’s IBC training materials.
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
Essentials of Laboratory Safety
IBC Best Practice Meeting November 30, 2016
Biosafety Overview for Laboratories
OSHA and Bloodborne Pathogens Training for the Medical Office
Waste and Contamination
BSL-1 Laboratory BIOHAZARD
Essentials of Laboratory Safety
Essentials of Laboratory Safety
Bloodborne Pathogens Exposure Control
Human Gene Therapy Institutional Review Procedures
CHemical Inventory Management and
Presentation transcript:

Recombinant DNA Training for Research Group Members How to Use this Training Template Principal Investigators (PIs) whose research involves recombinant DNA are required by NIH to provide their research group members training on lab-specific hazards and emergency procedures. The Berkeley Biosafety has prepared this PowerPoint presentation template to assist PIs in meeting this requirement. Text in italics [example] indicates where the template should be modified to accurately reflect your lab hazards and procedures.

Working with Recombinant DNA in the _[name of PI]_ Laboratory [Name of PI] [Name of Department] [Date Training Is Given]

Basic Requirements Research involving recombinant DNA is closely regulated by the National Institutes of Health (NIH), and requires a Biological Use Authorization (BUA) approved by the Berkeley campus Committee on Laboratory & Environmental Biosafety (CLEB). CLEB works with the campus Biosafety Program, which can provide additional guidance

Basic Requirements (Cont’d) All work involving recombinant DNA – regardless of funding source -- must adhere to the mandatory NIH “Guidelines for Research Involving recombinant DNA Molecules” found at _oba.html _oba.html _oba.html

Purpose of This Training Section IV-B-7-d-(2) of the NIH Guidelines The NIH requires that the PI provide lab- specific biosafety training on the hazards of the specific experimental procedures used in their laboratory to members of their research group. One way to document this training is to record it in the minutes of a group meeting, listing all participants.

Contents of This Training CLEB Administrative Requirements CLEB Administrative Requirements What are the NIH Guidelines? What are the NIH Guidelines? Role of the Investigator/Lab Staff Role of the Investigator/Lab Staff Description of the Experiment-BUA Description of the Experiment-BUA –The Agents Used –The Template Risk Assessment/Biosafety Level Risk Assessment/Biosafety Level –Good Work Practices –Personal Protective Equipment –Engineering Controls Waste Disposal/Decontamination Waste Disposal/Decontamination Emergency Procedures Emergency Procedures

CLEB Administrative Requirements CLEB requires the following from every PI approved to use recombinant DNA: CLEB requires the following from every PI approved to use recombinant DNA: –Train all research group members on lab- specific hazards and procedures –Report incidents involving recombinant DNA immediately to EH&S –Submit a BUA amendment for any change in personnel or Scope of Work

What are the NIH Guidelines? Key Sections of the NIH Guidelines Appendix B-List of Agents Appendix B-List of Agents Section III-Types of Experiments involving recombinant DNA Section III-Types of Experiments involving recombinant DNA Appendix G-Level of Containment Appendix G-Level of Containment Appendix K-Large Scale Appendix K-Large Scale Appendix M-Gene Transfer/Human Subjects Appendix M-Gene Transfer/Human Subjects Appendix P-Transgenic Plants Appendix P-Transgenic Plants Appendix Q-Transgenic Animals Appendix Q-Transgenic Animals Section IV-Responsibilities of PI, IBC Section IV-Responsibilities of PI, IBC

PI RESPONSIBILITIES Section IV-B-7: ROLE OF THE PI On behalf of the institution, the Principal Investigator is responsible for full compliance with the NIH Guidelines for any recombinant DNA research. The PI must: The PI must: Not initiate or modify recombinant DNA research which requires CLEB approval until that research has been approved by CLEB and has met all other requirements of the NIH Guidelines. Not initiate or modify recombinant DNA research which requires CLEB approval until that research has been approved by CLEB and has met all other requirements of the NIH Guidelines. Report any significant problems, violations of the NIH Guidelines, or any significant research-related accidents and illnesses to the Biological Safety Officer and CLEB. Report any significant problems, violations of the NIH Guidelines, or any significant research-related accidents and illnesses to the Biological Safety Officer and CLEB.

OTHER PI RESPONSIBILITIES ResponsibilityNIH Guideline Reference Train Lab Staff (Micro technique)Section IV-B-7-a, d Train Lab Staff (Micro technique)Section IV-B-7-a, d Ship Agents SafelySection IV-B-7-a Ship Agents SafelySection IV-B-7-a Follow Emergency PlansSection IV-B-7-a Follow Emergency PlansSection IV-B-7-a Notify NIH of novel host/vectorsSection IV-B-7-b Notify NIH of novel host/vectorsSection IV-B-7-b Update ProtocolSection IV-B-7-c Update ProtocolSection IV-B-7-c Notify IBC/CLEB of incident Section IV-B-7-e Notify IBC/CLEB of incident Section IV-B-7-e Make Protocol AvailableSection IV-B-7-d Make Protocol AvailableSection IV-B-7-d Offer Medical SurveillanceSection IV-B-7-d Offer Medical SurveillanceSection IV-B-7-d Supervise Lab MembersSection IV-B-7-e Supervise Lab MembersSection IV-B-7-e Maintain Safety EquipmentSection IV-B-7-e Maintain Safety EquipmentSection IV-B-7-e

Description of the Experiment-BUA The Scope of Work [Cut and paste scope of work narrative from your BUA] [Cut and paste scope of work narrative from your BUA]

Description of the Experiment-BUA The Agents Used [List the agents, recombinant DNA host/vector systems, human cell lines, packaging cell lines, and clinical specimens used in the experiment. Include all etiological agents.]

Description of the Experiment-BUA The Risks That May Affect Containment Level These are some of the common experimental risks associated with our research: [modify list as appropriate] These are some of the common experimental risks associated with our research: [modify list as appropriate] –Route(s) of exposure –volumes of culture –aerosol generating procedures –Procedures involving sharps –high concentrations –the use of vectors and vulnerable animals –inserted genetic sequences that increase virulence –the use of drug/antibiotic resistant strains

Description of the Experiment-BUA The Risks That May Affect Containment Level These are the symptoms of exposure with the agents we use: These are the symptoms of exposure with the agents we use: –[List symptoms of exposure]

Our Recombinant DNA Experiment Template [Cut and paste from BUA form:] Agent Characteristics: Agent Characteristics: Routes of Exposure: Routes of Exposure: Host: Host: Vector: Vector: Nature of inserted sequences: Nature of inserted sequences: Source of inserted sequences: Source of inserted sequences: Types of manipulation: Types of manipulation: Attempt to express foreign gene: Attempt to express foreign gene: Protein produced: Protein produced: Containment: Containment: Section of Guidelines: Section of Guidelines:

Risk Assessment/Biosafety Level Good Work Practices [Modify list as appropriate] Wash Hands Frequently Wash Hands Frequently Use Personal Protective Equipment and Engineering Controls Use Personal Protective Equipment and Engineering Controls Minimize Use of Sharps Minimize Use of Sharps Do Not Eat, Drink, or Smoke in the lab Do Not Eat, Drink, or Smoke in the lab Disinfect Work Areas Disinfect Work Areas

Risk Assessment/Biosafety Level Personal Protective Equipment [Modify list as appropriate] The following personal protective equipment must be worn when handling agents in the tissue culture room and the biosafety cabinet: The following personal protective equipment must be worn when handling agents in the tissue culture room and the biosafety cabinet: –Latex or nitrile gloves –Lab coat –Safety glasses

Risk Assessment/Biosafety Level Engineering Controls [Modify list as appropriate] The following engineering controls must be used whenever handling agents in the tissue culture room: The following engineering controls must be used whenever handling agents in the tissue culture room: –Biosafety cabinet –Sink for Hand Washing –Mechanical pipettes –Sealed vials –Sharps containers/Broken Glass box –Eyewash/deluge shower (use only in an emergency)

Waste Disposal/Decontamination [Modify list as appropriate] Liquid waste will be treated with 10% household bleach and allowed to set for 20 minutes and drain-disposed. Solid red bag wastes will be placed in a red-bag lined bin and transferred to the _________ Building, Room______ medical waste storage area for pick up and disposal. Liquid waste will be treated with 10% household bleach and allowed to set for 20 minutes and drain-disposed. Solid red bag wastes will be placed in a red-bag lined bin and transferred to the _________ Building, Room______ medical waste storage area for pick up and disposal. Work areas must be disinfected with dilute bleach and 70% ethanol. Work areas must be disinfected with dilute bleach and 70% ethanol.

Emergency Procedures [modify as appropriate] In the event of a laboratory accident: In the event of a laboratory accident: –Tend to injured person –Notify the PI or the lab supervisor; inform the PI IMMEDIATELY if recombinant DNA was involved so that CLEB and the Biosafety Officer can be notified within 24 hrs. –Initiate clean up procedures. –Notify EHS, if the PI is not available, or (After Hours) –Seek medical attention at Tang or the Alta Bates ER at 2450 Ashby Avenue after hours.

Conclusion This training is designed to inform you of the NIH requirements regarding use of recombinant DNA, and our lab’s implementation of the NIH requirements. All recombinant DNA experiments require BUA approval by CLEB and any changes require an approved amendment to the BUA. If you have any questions on this training, let me know, and I will contact the Biosafety Officer for assistance.